Actively Recruiting
Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy
Led by Federico II University · Updated on 2026-01-29
1500
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluation of adherence, persistence and efficacy of treatment with alirocumab 300 mg in a real-life Italian population.
CONDITIONS
Official Title
Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients under alirocumab 300mg treatment.
You will not qualify if you...
- Age less than 18 years or greater than 80 years.
- Patients who refuse to participate and to sign informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Federico II University of Naples, Department of Advanced Biomedical Sciences
Naples, Napoli, Italy, 80131
Actively Recruiting
Research Team
P
Pasquale Perrone Filardi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here